Adaptive Biotechnologies (ADPT) Other Accumulated Expenses (2018 - 2025)

Adaptive Biotechnologies has reported Other Accumulated Expenses for 8 years, with the latest figure at $826000.0 in Q4 2025.

• Quarterly Other Accumulated Expenses changed 0.48% year-over-year to $826000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $826000.0 (changed 0.48% YoY) and the FY2025 annual result came in at $826000.0, changed 0.48% from the prior year.
• Other Accumulated Expenses steadied at $826000.0 in Q4 2025 per ADPT's latest filing, from $830000.0 in the prior quarter.
• Over five years, Other Accumulated Expenses peaked at $1.7 million in Q4 2022 and troughed at $763000.0 in Q4 2023.
• A 5-year average of $1.0 million and a median of $830000.0 in 2024 frame the typical range for Other Accumulated Expenses.
• The sharpest annual moves came in 2022 and 2023: Other Accumulated Expenses surged 58.52% in 2022, then tumbled 53.9% in 2023.
• Over 5 years, Other Accumulated Expenses stood at $1.0 million in 2021, then soared by 58.52% to $1.7 million in 2022, then sank by 53.9% to $763000.0 in 2023, then gained by 8.78% to $830000.0 in 2024, then slipped by 0.48% to $826000.0 in 2025.
• According to Business Quant data, Other Accumulated Expenses over the past three periods registered $826000.0, $830000.0, and $763000.0 for Q4 2025, Q4 2024, and Q4 2023 respectively.